EssilorLuxottica Société anonyme (ESLOY)
USD 139.72
(2.99%)
USD 139.72
(2.99%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.75 Billion EUR | -1.4% |
| 2022 | 2.78 Billion EUR | 14.07% |
| 2021 | 2.44 Billion EUR | 26.68% |
| 2020 | 1.93 Billion EUR | -10.9% |
| 2019 | 2.16 Billion EUR | 5.92% |
| 2018 | 2.04 Billion EUR | 86.42% |
| 2017 | 1.09 Billion EUR | -2.49% |
| 2016 | 1.12 Billion EUR | 2.37% |
| 2015 | 1.09 Billion EUR | 9.68% |
| 2014 | 1 Billion EUR | 15.3% |
| 2013 | 869 Million EUR | 4.64% |
| 2012 | 830.47 Million EUR | 10.23% |
| 2011 | 753.41 Million EUR | 16.73% |
| 2010 | 645.45 Million EUR | 32.92% |
| 2009 | 485.6 Million EUR | 2.17% |
| 2008 | 475.29 Million EUR | 20.76% |
| 2007 | 393.59 Million EUR | 6.05% |
| 2006 | 371.13 Million EUR | 1.8% |
| 2005 | 364.55 Million EUR | 14.24% |
| 2004 | 319.12 Million EUR | 3.09% |
| 2003 | 309.56 Million EUR | -4.82% |
| 2002 | 325.23 Million EUR | -6.64% |
| 2001 | 348.38 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.98 Billion EUR | 8.51% |
| 2024 Q2 | 2.98 Billion EUR | 0.0% |
| 2023 Q2 | 2.91 Billion EUR | 0.0% |
| 2023 Q1 | 2.91 Billion EUR | 4.55% |
| 2023 Q4 | 2.75 Billion EUR | 0.0% |
| 2023 Q3 | 2.75 Billion EUR | -5.69% |
| 2023 FY | 2.75 Billion EUR | -1.4% |
| 2022 Q3 | 2.78 Billion EUR | -2.89% |
| 2022 Q4 | 2.78 Billion EUR | 0.0% |
| 2022 Q1 | 2.87 Billion EUR | 17.46% |
| 2022 FY | 2.78 Billion EUR | 14.07% |
| 2022 Q2 | 2.87 Billion EUR | 0.0% |
| 2021 FY | 2.44 Billion EUR | 26.68% |
| 2021 Q1 | 2.04 Billion EUR | 6.01% |
| 2021 Q4 | 2.44 Billion EUR | 0.0% |
| 2021 Q2 | 2.04 Billion EUR | 0.0% |
| 2021 Q3 | 2.44 Billion EUR | 19.5% |
| 2020 FY | 1.93 Billion EUR | -10.9% |
| 2020 Q3 | 1.93 Billion EUR | -10.98% |
| 2020 Q1 | 2.16 Billion EUR | 0.09% |
| 2020 Q4 | 1.93 Billion EUR | 0.0% |
| 2020 Q2 | 2.16 Billion EUR | 0.0% |
| 2019 Q1 | 2.12 Billion EUR | 3.91% |
| 2019 FY | 2.16 Billion EUR | 5.92% |
| 2019 Q3 | 2.16 Billion EUR | 1.93% |
| 2019 Q4 | 2.16 Billion EUR | 0.0% |
| 2019 Q2 | 2.12 Billion EUR | 0.0% |
| 2018 Q2 | 1.18 Billion EUR | 0.0% |
| 2018 FY | 2.04 Billion EUR | 86.42% |
| 2018 Q4 | 2.04 Billion EUR | 0.54% |
| 2018 Q3 | 2.03 Billion EUR | 72.08% |
| 2018 Q1 | 1.18 Billion EUR | 7.75% |
| 2017 Q4 | 1.09 Billion EUR | 31.85% |
| 2017 Q3 | 832 Million EUR | -26.24% |
| 2017 Q2 | 1.12 Billion EUR | 0.0% |
| 2017 Q1 | 1.12 Billion EUR | 0.27% |
| 2017 FY | 1.09 Billion EUR | -2.49% |
| 2016 Q2 | 1.12 Billion EUR | 0.0% |
| 2016 FY | 1.12 Billion EUR | 2.37% |
| 2016 Q1 | 1.12 Billion EUR | 2.46% |
| 2016 Q3 | 1.12 Billion EUR | -0.09% |
| 2016 Q4 | 1.12 Billion EUR | 0.0% |
| 2015 Q3 | 1.09 Billion EUR | 0.09% |
| 2015 FY | 1.09 Billion EUR | 9.68% |
| 2015 Q2 | 1.09 Billion EUR | 0.0% |
| 2015 Q4 | 1.09 Billion EUR | 0.0% |
| 2015 Q1 | 1.09 Billion EUR | 9.58% |
| 2014 Q2 | 929 Million EUR | 0.0% |
| 2014 FY | 1 Billion EUR | 15.3% |
| 2014 Q3 | 1 Billion EUR | 7.86% |
| 2014 Q4 | 1 Billion EUR | 0.0% |
| 2014 Q1 | 929 Million EUR | 6.9% |
| 2013 Q1 | 852.8 Million EUR | 2.69% |
| 2013 Q4 | 869 Million EUR | 0.0% |
| 2013 Q3 | 869 Million EUR | 1.9% |
| 2013 Q2 | 852.8 Million EUR | 0.0% |
| 2013 FY | 869 Million EUR | 4.64% |
| 2012 Q4 | 830.47 Million EUR | 0.0% |
| 2012 Q2 | 856.66 Million EUR | 0.0% |
| 2012 FY | 830.47 Million EUR | 10.23% |
| 2011 FY | 753.41 Million EUR | 16.73% |
| 2011 Q2 | 644.43 Million EUR | 0.0% |
| 2011 Q4 | 753.41 Million EUR | 0.0% |
| 2010 Q2 | 625.83 Million EUR | 0.0% |
| 2010 FY | 645.45 Million EUR | 32.92% |
| 2010 Q4 | 645.45 Million EUR | 0.0% |
| 2009 Q4 | 485.6 Million EUR | 0.0% |
| 2009 FY | 485.6 Million EUR | 2.17% |
| 2008 FY | 475.29 Million EUR | 20.76% |
| 2007 FY | 393.59 Million EUR | 6.05% |
| 2006 FY | 371.13 Million EUR | 1.8% |
| 2005 FY | 364.55 Million EUR | 14.24% |
| 2004 FY | 319.12 Million EUR | 3.09% |
| 2003 FY | 309.56 Million EUR | -4.82% |
| 2002 FY | 325.23 Million EUR | -6.64% |
| 2001 FY | 348.38 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -2054761.054% |
| Ansell Limited | 457.04 Million USD | -501.694% |
| Ansell Limited | 457.9 Million USD | -500.568% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -6245.817% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -9860064.934% |
| Psykey, Inc. | 49.94 Thousand USD | -5506507.93% |
| ConvaTec Group Plc | 395.54 Million USD | -595.251% |
| ConvaTec Group Plc | 396.1 Million USD | -594.269% |
| Encision Inc. | 1.4 Million USD | -196001.083% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 29589082.139% |
| LifePoint, Inc. | 2.3 Million USD | -118981.488% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -114340.283% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -623482.766% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -2992869.243% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -282736.552% |
| SmileDirectClub, Inc. | 49.87 Million USD | -5413.895% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | -681.807% |
| SheerVision, Inc. | 339.66 Thousand USD | -809526.012% |
| United Health Products, Inc. | 33.59 Thousand USD | -8184911.013% |
| Vasamed, Inc. | 449.02 Thousand USD | -612333.968% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -32144844.477% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -853478.667% |